This came after Sun Pharma presented the BE study report along with revised clinical trial (CT) protocol no. ICR/23/013 ver.

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Compounded semaglutide helps manage blood sugar and curb appetite for better diabetes control and weight loss. Learn how it ...

As obesity rates rise among individuals with T1D, GLP-1 agonist medications, indicated for T2D and weight loss, are ...

Research reveals GLP-1 receptor agonists influence gut microbiome, enhancing metabolic health and offering anti-inflammatory ...

The escalating global prevalence of obesity and type 2 diabetes mellitus (T2DM) underscores the urgent need for innovative ...

In the 1980s, Habener was working at Massachusetts General Hospital (MGH) and studying hormones, including glucagon, which increases blood glucose, in type 2 diabetes. On cloning the gene encoding ...

The therapeutic potential of targeting glucagon-like peptide-1 (GLP-1 ... Unlike traditional insulin therapies, GLP-1 RAs enhance insulin secretion only when blood glucose levels are elevated, ...

Plasma iron and ferritin levels increase in T2DM patients. Iron accumulates in liver cells and leads to insulin resistance and reduced secretion through oxidative stress pathways. In addition, free ...

Michael R. Rickels “The full dose of VX-880, given as a single infusion, demonstrates consistent engraftment of islets with restoration of endogenous insulin secretion, elimination of severe ...

“Both human and animal studies have shown that capsaicin and phenolic compounds have some potential benefits of improving glycemic control through slowing glucose absorption and increasing insulin ...